CGM Associated with Reduced Cost and Health Care Resource Utilization in Intensive Insulin-Treated T2D – Advances in Therapy – April 15, 2024
CGM Improves Glycemic Control and Reduces CVD Risk in Non-Insulin-Treated T2D – Diabetes Obesity and Metabolism – April 28, 2024